Abstract
Publication details
- DOI
- 10.5001/omj.2025.111
- Journal
- Oman Medical Journal, 41(2)
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
- License
- CC BY-NC 4.0
Cite this article
APA 7
Al-Busafi, S. A. (2026). Letter in Reply: Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection. Oman Medical Journal, 41(2). https://doi.org/10.5001/omj.2025.111
MLA 9
Al-Busafi, Said A. "Letter in Reply: Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection." Oman Medical Journal, vol. 41, no. 2, 2026. https://doi.org/10.5001/omj.2025.111.
Chicago (author–date)
Al-Busafi, Said A. 2026. "Letter in Reply: Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection." Oman Medical Journal 41 (2). https://doi.org/10.5001/omj.2025.111.
Harvard
Al-Busafi, S. A. (2026) 'Letter in Reply: Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection', Oman Medical Journal, 41(2). doi:10.5001/omj.2025.111.
Vancouver
Al-Busafi SA. Letter in Reply: Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection. Oman Medical Journal. 2026;41(2). doi:10.5001/omj.2025.111
IEEE
S. A. Al-Busafi, "Letter in Reply: Prevalence and Risk Factors of Significant Hepatic Fibrosis in Omani Patients with HBeAg-negative Chronic Hepatitis B Virus Infection," Oman Medical Journal, vol. 41, no. 2, 2026, doi: 10.5001/omj.2025.111.